Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer
2011
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
2019 Standout
Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections
1996
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Preoperative assessment of the high-risk patient for lung resection
1996
Exercise oximetry versus spirometry in the assessment of risk prior to lung resection
1995
Le traitement chirurgical du cancer bronchique non à petites cellules
2004
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma
2001
Invasive exercise testing in the evaluation of patients at high-risk for lung resection
1998
Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC
2005
Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma
1999
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
2003 Standout
Regional Lymph Node Classification for Lung Cancer Staging
1997 Standout
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
2002 Standout
Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer
2004
PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
1999
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304)
2004
Guidelines on the radical management of patients with lung cancer
2010
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Relationship of shuttle walk test and lung cancer surgical outcome
2004
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Preoperative versus Postoperative Chemotherapy in Patients with Resectable Non-small Cell Lung Cancer: Systematic Review and Indirect Comparison Meta-Analysis of Randomized Trials
2009
Reported management of lung cancer in Victoria in 1993: comparison with best practice
2000
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Treatment of Non-small Cell Lung Cancer-Stage IIIA
2007
Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238
2007
Prognostic factors in non-small cell lung cancer surgery
2005
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome
2006
Surgery for stage IIIa-N2 non-small cell lung cancer
1994
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
2020
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Resection rates and postoperative mortality in 7,899 patients with lung cancer
1996
Malignant Effusive Disease of the Pleura and Pericardium
1997
Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non–small cell lung cancer
2007
Esophageal Cancer
2003 Standout
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
1999
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer
1999
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Preoperative chemotherapy for non-small cell lung cancer
2001
Conformity index: A review
2006 Standout
The role of chemotherapy in early stage of non-small cell lung cancer
2001
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study
1998
Preoperative chemotherapy in stage III non-small cell lung cancer: long-term outcome
1999
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Preoperative chemotherapy for lung cancer does not increase surgical morbidity
2001
Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan
1997
Predictors of early morbidity after major lung resection in patients with and without airflow limitation
2002
Evaluation of Expiratory Volume, Diffusion Capacity, and Exercise Tolerance Following Major Lung Resection
2007
POSTOPERATIVE PULMONARY COMPLICATIONS
2001
Lung Volume Reduction Surgery Alters Management of Pulmonary Nodules in Patients With Severe COPD
1997
Clinical Exercise Testing
2001
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy
2008
Taxanes in the Treatment of Non-Small Cell Lung Cancer
2006
Cellular processing of platinum anticancer drugs
2005 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Cardiopulmonary Exercise Testing in the Preoperative Assessment for Lung Resection Surgery
2001
Epidemiology of Esophageal Cancer, Especially Adenocarcinoma of the Esophagus and Esophagogastric Junction
2000
Oesophageal carcinoma
2013 Standout
Postoperative complications in relation with induction therapy for lung cancer
2001
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
2005
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
2005
Orthotopic growth and metastasis of human non-small cell lung carcinoma cells injected into the pleural cavity of nude mice
1998
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection
2001
EPIDEMIOLOGY OF COLUMNAR-LINED ESOPHAGUS AND ADENOCARCINOMA
1997
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
2004
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery
2007
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
2002
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Induction chemotherapy increases perioperative complications in patients undergoing resection for non–small cell lung cancer
2001
Functional evaluation before lung resection
2002
Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer
2007
Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis
2001
The impact of three-dimensional radiation on the treatment of non-small cell lung cancer
2000
Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
1996
Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection
2005
Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer
2000
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
2009
Factors associated with false-positive staging of lung cancer by positron emission tomography
2000
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
1997
Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy
2004
Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography and Computed Tomography Scans
2004
Standardized exercise oximetry predicts postpneumonectomy outcome
1997
Operative complications and early mortality after induction therapy for lung cancer
2007
PEGylation, successful approach to drug delivery
2005 Standout
Functional evaluation of the lung resection candidate
1998
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
1997
Risks of Neoadjuvant Chemotherapy and Radiation Therapy
2008
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
2003
What Happens to Patients Undergoing Lung Cancer Surgery?
2002
Framework PEACE: An organizational model for examining physical exercise across the cancer experience
2001
Lung Reduction Operation and Resection of Pulmonary Nodules in Patients With Severe Emphysema
1998
Revisions in the International System for Staging Lung Cancer
1997 Standout
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.
1995
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
2007
Complications of lung resection and exercise capacity: A meta-analysis
2007
Platinum drugs in the treatment of non-small-cell lung cancer
2002
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
1998
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Advantages of Positron Emission Tomography over Computed Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer
2002
PRIMARY MALIGNANT TUMORS OF THE CHEST WALL: The Memorial Sloan-Kettering Cancer Center Experience
1994
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Role of CO Diffusing Capacity during Exercise in the Preoperative Evaluation for Lung Resection
2000
Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
2010
From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
2006
The Epidemiology of Osteosarcoma
2009 Standout
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Preoperative evaluation of the lung cancer resection candidate
2010
Chemotherapy for advanced gastric cancer
2017 Standout
Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer Resection
2004
A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
2006
Surgical Management of Esophageal Carcinoma
1999
Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment
2005
A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer.
2006
The role of radiotherapy in cancer treatment
2005 Standout
Factors affecting long term survival following resection for lung cancer.
1996
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
1998
Mortality after Esophagectomy: Risk Factor Analysis
1997
Palliative endobronchial brachytherapy for non-small cell lung cancer
2012
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
1999
Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer
1999
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
2008
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Management of Gastroesophageal Tumors
2007
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Cardiopulmonary Exercise Tests and Lung Cancer Surgical Outcome
2005
A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
2006
A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma
1996
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Guidelines on the selection of patients with lung cancer for surgery
2001
Relationships between operative approaches and outcomes in esophageal cancer
1998
Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer
2002
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma
1998
Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901
2007
Works of Michael Ryan being referenced
Exercise Testing in the Evaluation of Patients at High Risk for Complications from Lung Resection
1992
High dose endobronchial irradiation in recurrent bronchogenic carcinoma
1992
A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
1994
Eleven years' experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions
1995
Comparison of three techniques of esophagectomy within a residency training program
1994
Prognostic significance of computed tomography in resected N2 lung cancer
1992
Resectability of Small-Cell Lung Cancer Following Induction Chemotherapy in Patients with Limited Disease (Stage II-IIIb)
1991
TCGASpliceSeq a compendium of alternative mRNA splicing in cancer
2015
Current Management of Chest-Wall Tumors
1989
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
1998
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
1993
Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption
1994